Qingdao Haier BiomedicalLtd Valuation

Q: What is the Fair Price of 688139 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

688139 (CN¥33.28) is trading above our estimate of [[fair value]] (CN¥0.36)

Is 688139 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688139 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688139 (CN¥33.28) is trading above our estimate of fair value (CN¥0.36)

Significantly Below Fair Value: 688139 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688139?

Key metric: As 688139 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688139. This is calculated by dividing 688139's market cap by their current earnings.
What is 688139's PE Ratio?
PE Ratio	29.3x
Earnings	CN¥358.01m
Market Cap	CN¥10.51b

688139 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4x
Enterprise Value/EBITDA	22.4x
PEG Ratio	1x

Price to Earnings Ratio vs Peers

How does 688139's PE Ratio compare to its peers?

The above table shows the PE ratio for 688139 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	40.5x
688575 Shenzhen YHLO Biotech	35.3x	38.1%	CN¥10.2b
600587 Shinva Medical InstrumentLtd	15.4x	22.3%	CN¥10.7b
301363 MeHow Innovative	45.8x	31.5%	CN¥12.4b
300171 Tofflon Science and Technology Group	65.7x	32.3%	CN¥11.1b
688139 Qingdao Haier BiomedicalLtd	29.3x	30.1%	CN¥10.5b

Price-To-Earnings vs Peers: 688139 is good value based on its Price-To-Earnings Ratio (29.3x) compared to the peer average (40.5x).

Price to Earnings Ratio vs Industry

How does 688139's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688139 is good value based on its Price-To-Earnings Ratio (29.3x) compared to the CN Medical Equipment industry average (34.5x).

Price to Earnings Ratio vs Fair Ratio

What is 688139's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688139 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	29.3x
Fair PE Ratio	33.7x

Price-To-Earnings vs Fair Ratio: 688139 is good value based on its Price-To-Earnings Ratio (29.3x) compared to the estimated Fair Price-To-Earnings Ratio (33.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Innovita Biological Technology

CN¥6.0b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥43.81

5.0%

24.4%

Chison Medical Technologies

CN¥3.0b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥26.51

10.2%

-38.4%

Truking Technology

CN¥4.8b

Engages in medical equipment business in China and internationally.

300358

CN¥8.07

6.0%

-29.9%